Skip to content

study of the analgesic effect of fentanyl, fentanyl with ibuprofen, fentanyl with apotel and fentanyl with ketorolac in patients with renal colic

study of the analgesic effect of fentanyl, fentanyl with ibuprofen, fentanyl with apotel and fentanyl with ketorolac on the reduction of pain and duration of hospitalization in patients with renal colic

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220421054605N1
Enrollment
200
Registered
2022-05-31
Start date
2022-06-10
Completion date
Unknown
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal colic. Unspecified renal colic

Interventions

Intervention 1: Intervention group 1: In this group, fentanyl (Darou Pakhsh Company) with a dose of 50 µg is administered as intravenous infusion. Intervention 2: Intervention group 2: For patients i

Sponsors

Shahre-kord University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients over the age of 18 have renal colic have stable hemodynamics(pulse rate(PR)=60-100,systolic blood pressure(SBP)>100,respiratory rate(RR)=8-22,functional oxygen saturation(SPO2)>90%) Have informed consent to participate in this study Don't have any of the following: Pregnancy/Asthma / chronic obstructive pulmonary disease(COPD)/ Intestinal obstruction/ Hypertension and heart failure/ Previous pulmonary surgery of the kidney and urinary tract/ Peptic ulcer/ Gastrointestinal bleeding/ Previous allergies to fentanyl or other analgesics / Loss of consciousness/ Trauma Head and chest/pneumocephalus/pneumothorax/Drug addiction/tenderness and abdominal rebound/Guarding abdomen/menstruation retarded/Use of analgesics in the past 24 hours No liver failure and bilateral renal failure

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain score. Timepoint: At the beginning of the study and at 5, 10? 15? 20? 25 and 30 minutes after the intervention. Method of measurement: Visual Analogue Scale (VAS).

Secondary

MeasureTime frame
Mean Arterial Pressure. Timepoint: At the beginning of the study and at 5, 10? 15? 20? 25 and 30 minutes after the intervention. Method of measurement: Monitoring device.;Hear rate. Timepoint: At the beginning of the study and at 5, 10? 15? 20? 25 and 30 minutes after the intervention. Method of measurement: Monitoring device.;Percentage of blood oxygen. Timepoint: At the beginning of the study and at 5, 10? 15? 20? 25 and 30 minutes after the intervention. Method of measurement: Monitoring device.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAbdul Rahim Sane'i Dehkordy

Shahre-kord University of Medical Sciences

zahedifatemeh744@gmail.com+98 38 3333 0061

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026